The discovery of immune checkpoints has revolutionized the application of immunotherapy in the treatment of metastatic CRC.11, 12 Studies have shown that TGFβ is elevated in the tumor microenvironment which enables tumor cells to evade immune killing. The gene discussed is TGFB1; the disease is neoplasm.